Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-12-24T14:54:42.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a revision note indicating the site version was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:42:45.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Publications section now states entries are automatically filled from PubMed and may not relate to the study, and the revision tag was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:40:48.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The notice about government funding and potential data updates was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:50:40.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    No significant changes detected on the page; the study title, overview, eligibility criteria, and locations appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:15:02.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Overall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T10:21:42.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.